Immunosuppressive Therapy with Cyclosporine May Result in Acute Rejection in Post Liver Transplant Patients Treated with Ledipasvir/Sofosbuvir for Hepatitis C

被引：0
|
作者：
Zachariah, Robin [1 ]
Venkat, Deepak [1 ]
机构：
[1] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-01795
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1795
引用
收藏
页码：S859 / S859
页数：1
相关论文
共 50 条
  • [1] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    HEPATOLOGY, 2016, 64 : 810A - 810A
  • [2] SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE
    Selim, K.
    Elhazin, B.
    Long, W.
    Karmanova, M.
    Salazar, J.
    Volk, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S789
  • [3] Sofosbuvir plus ledipasvir for recurrent hepatitis C in liver transplant recipients
    Altraif, Ibrahim Hamad
    LIVER TRANSPLANTATION, 2017, 23 (04) : 554 - 556
  • [4] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
    Vinaixa, Carmen
    Berenguer, Marina
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 322 - 323
  • [5] Large Single-Center Experience of Sofosbuvir and Ledipasvir Therapy for the Treatment of Post-Liver Transplant Patients with Hepatitis C Virus.
    Wedd, J.
    Ford, R.
    Norvell, J.
    Parekh, S.
    Cheng, N.
    Young, N.
    Patel, A.
    Maheshwari, R.
    Vora, R.
    Mgbemena, O.
    Spivey, J.
    Pillai, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 298 - 298
  • [6] Acute liver failure during hepatitis C treatment with sofosbuvir and ledipasvir
    Debes, Jose D.
    Ricci, Paola
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (12) : 1091 - 1092
  • [7] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    HEPATOLOGY, 2016, 64 : 995A - 996A
  • [8] Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting
    Abaalkhail, Faisal
    Elsiesy, Hussein
    Elbeshbeshy, Hany
    Shawkat, Mohamed
    Yousif, Sarra
    Ullah, Waheed
    Alabbad, Saleh
    Al-jedai, Ahmed
    Ajlan, Aziza
    Broering, Dieter
    Saab, Sammy
    Al Sebayel, Mohammed
    Al-Hamoudi, Waleed
    TRANSPLANTATION, 2017, 101 (11) : 2739 - 2745
  • [9] Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation
    Kawaoka T.
    Imamura M.
    Morio K.
    Nakamura Y.
    Tsuge M.
    Nelson Hayes C.
    Kawakami Y.
    Aikata H.
    Ochi H.
    Ishiyama K.
    Ohdan H.
    Chayama K.
    Clinical Journal of Gastroenterology, 2017, 10 (2) : 179 - 184
  • [10] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir I Sofosbuvir Plus Ribavirin Pretransplant
    Yoshida, Eric M.
    Kwo, Paul
    Agarwal, Kosh
    Duvoux, Christophe
    Durand, Francois
    Peck-Radosavljevic, Markus
    Lilly, Leslie
    Willems, Bernard
    Vargas, Hugo
    Kumar, Princy
    Brown, Robert S., Jr.
    Horsmans, Yves
    De-Oertel, Shampa
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brainard, Diana M.
    McHutchison, John G.
    Terrault, Norah
    Rizzetto, Mario
    Muellhaupt, Beat
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 375 - 381
12345